| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.23 | 2e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 3e-05 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.87 | 0.0003 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.17 | 0.0008 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.16 | 0.002 |